Gene · 27165
Papers2,122
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,122
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Arginine methyltransferase PRMT1 promotes ferroptosis through EGR1/GLS2 axis in sepsis-related acute lung injury. | Commun Biol | 2025 | 39901028 | PubTator, text mining | PubMed |
| Alzheimer's disease: an integrative bioinformatics and machine learning analysis reveals glutamine metabolism-associated gene biomarkers. | BMC Pharmacol Toxicol | 2025 | 39875978 | PubTator, text mining | PubMed |
| The prognostic importance of the negative regulators of ferroptosis, GPX4 and HSPB1, in patients with colorectal cancer. | Oncol Lett | 2025 | 39850719 | PubTator, text mining | PubMed |
| Glutaminase-2 Expression Induces Metabolic Changes and Regulates Pyruvate Dehydrogenase Activity in Glioblastoma Cells. | Int J Mol Sci | 2025 | 39796278 | PubTator, text mining | PubMed |
| Glutamine metabolism is essential for coronavirus replication in host cells and in mice. | J Biol Chem | 2025 | 39662828 | PubTator, text mining | PubMed |
| Atypical POEMS syndrome: Report of a patient. | Med Clin (Barc) | 2025 | 39214730 | PubTator, text mining | PubMed |
| Perirhinal cortex to the nucleus accumbens circuit in novelty salience following methamphetamine self-administration. | Addict Neurosci | 2024 | 39664755 | PubTator, text mining | PubMed |
| GLS2 links glutamine metabolism and atherosclerosis by remodeling artery walls. | Nat Cardiovasc Res | 2024 | 39562782 | PubTator, text mining | PubMed |
| Efficacy of probiotics combined with enteral nutrition therapy on intestinal flora, digestive tract symptoms and endogenous environment in patients with gastric cancer undergoing chemotherapy. | Pak J Med Sci | 2024 | 39554672 | PubTator, text mining | PubMed |
| N-Acetylneuraminic acid triggers endothelial pyroptosis and promotes atherosclerosis progression via GLS2-mediated glutaminolysis pathway. | Cell Death Discov | 2024 | 39537619 | PubTator, text mining | PubMed |
| The Anti-proliferative Effect of a Novel Glutaminase Inhibitor IN-3 on Prostate Cancer Cells. | Medeni Med J | 2024 | 39350531 | PubTator, text mining | PubMed |
| Glutaminase 2 as a therapeutic target in glioblastoma. | Biochim Biophys Acta Rev Cancer | 2024 | 39293549 | PubTator, text mining | PubMed |
| Glutaminase 1 plays critical roles in myelodysplastic syndrome and acute myeloid leukemia cells. | Cancer Biomark | 2024 | 39213050 | PubTator, text mining | PubMed |
| Features that characterize monoclonal light chain ("myeloma") cast nephropathy with immunofluorescence challenges and emphasis on electron microscopy. | Ultrastruct Pathol | 2024 | 39166773 | PubTator, text mining | PubMed |
| Clavulanic acid inhibits methamphetamine locomotor sensitization in mice and normalizes methamphetamine-induced changes in glutaminase mRNA levels in the nucleus accumbens. | Physiol Behav | 2024 | 39053627 | PubTator, text mining | PubMed |
| Duffy Antigen Receptor for Chemokines (DARC) Nanodisc-Based Biosensor for Detection of Staphylococcal Bicomponent Pore-Forming Leukocidins. | ACS Appl Mater Interfaces | 2024 | 39007843 | PubTator, text mining | PubMed |
| Effects of Konjac Glucomannan and Its Oligosaccharides on Improvement of Lactose Intolerance as Gut Prebiotics. | ACS Omega | 2024 | 39005821 | PubTator, text mining | PubMed |
| CISD2 downregulation participates in the ferroptosis process of human ovarian SKOV-3 cells through modulating the wild type p53-mediated GLS2/SAT1/SLC7A11 and Gpx4/TRF signaling pathway. | Tissue Cell | 2024 | 38991271 | PubTator, text mining | PubMed |
| A precise microdissection strategy enabled spatial heterogeneity analysis on the targeted region of formalin-fixed paraffin-embedded tissues. | Talanta | 2024 | 38963978 | PubTator, text mining | PubMed |
| Glutaminase - A potential target for cancer treatment. | Biomedicine (Taipei) | 2024 | 38939098 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/27165/papers?page=5